NYSE$DOCS

Doximity Inc. · Q2 2026 earnings

Q2 2026 earnings · · After market close · Investor relations

Briefing

Doximity reported fiscal Q2 2026 revenue of $168.5M with net income of $62.1M and diluted EPS of $0.31.

Second-quarter revenue was $168.5 million with net income of $62.1 million and diluted EPS of $0.31. The physician-network platform reported higher engagement across its subscription and hiring solutions in the 10-Q.

  • Q2 FY26 revenue $168.5M.
  • Net income $62.1M; diluted EPS $0.31.
  • Net income margin about 37% for the quarter.
  • Six-month revenue $314.4M; net income $115.4M.

Headline financials

Total Revenue

$169M

No prior period
EPS (adj)

$0.31

No prior period
Adj. EBITDA Margin

59.8%

No prior period
Net Income Margin

36.8%

No prior period
Non-GAAP Net Income

$90M

No prior period
Non-GAAP Net Income Margin

53.4%

No prior period
Operating Cash Flow

$93.9M

No prior period
Adjusted EBITDA

$101M

No prior period
Net Income

$62.1M

No prior period
Operating Income

$63.7M

No prior period
Gross Profit

$152M

No prior period

Revenue & EPS history

Doximity · Revenue · Quarterly

$169M

Q2 2026
Beat estimate in 13 of 14 quarters(93%)
ActualEstimate

Forward guidance

The filing discusses Doximity's outlook for upcoming periods, including capital allocation, operating priorities, and market risks disclosed in the quarterly report.

Tailwinds

  • Doximity cites operational execution and demand trends supporting the outlook.
  • Balance sheet and liquidity actions aim to fund growth and returns.

Headwinds

  • Macro, pricing, and input-cost volatility could pressure margins.
  • Segment mix and one-time items may affect quarter-to-quarter comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q2 2026

Historical avgQ2 2026

+5.5%

Avg return

Earnings day

+2.9%

Avg return

5 days after

+3.3%

Avg return

30 days after

64%

14 / 22 earnings

Positive

+45.6%

Q2 2023

Best reaction

-26.6%

Q1 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026+5.3%-17.6%-14.3%
Q3 2026-16.8%-22.1%-23.9%
Q2 2026-13.0%-18.6%-26.6%
Q1 2026+13.4%+9.3%+18.4%
Q4 2025-10.1%-13.2%-4.3%
Q3 2025+36.0%+29.0%+9.8%
Q4 2024+17.5%+18.1%+25.2%
Q3 2024+4.3%+5.9%+1.9%
Q2 2024+13.1%+20.6%+16.3%
Q1 2024-26.6%-30.9%-31.6%
Q4 2023-6.4%-6.2%-5.2%
Q3 2023-14.9%-11.0%-22.0%
Q2 2023+45.6%+36.6%+48.5%
Q1 2023-11.1%-13.1%-22.2%
Q4 2020+3.2%+4.7%+22.3%
Q4 2022-8.1%-4.3%-1.9%
Q3 2021+21.1%+13.9%-6.8%
Q3 2022+27.3%+16.1%+2.9%
Q2 2021+0.2%-7.5%-29.5%
Q2 2022+1.4%+3.4%-19.1%
Q4 2021+8.0%+7.8%+44.9%
Q1 2022+31.5%+41.9%+89.2%
Q1 2021
Q3 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro